Can a smartphone app help young sarcoma survivors manage pain?
NCT ID NCT07402577
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study is testing whether a 3-month daily survey program (called ecological momentary assessment) is practical and acceptable for tracking chronic pain and opioid use in adolescent and young adult sarcoma survivors. About 40 survivors aged 12 to 24 at diagnosis, who still have meaningful pain, will use their smartphones to answer daily questions. The goal is to see if this approach works for future research, not to treat pain directly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that daily surveys are a practical way to monitor pain and opioid use in young sarcoma survivors, pointing toward better pain management strategies.
- What could go wrong
- This is a very small, early feasibility study with only 40 participants. It does not test any treatment, so it may not lead to direct improvements in pain or opioid use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD SARCOMA OF SOFT TISSUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Roswell Park Comprehensive Cancer Center
RECRUITINGBuffalo, New York, 14263, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can engineered immune cells tackle childhood sarcoma?
- Can a Patient's own immune cells be engineered to fight a rare sarcoma?
- Can a Patient's own immune cells fight advanced sarcoma?
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a new protein drug shield kids with cancer from dangerous infections?
- Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?